Expression of Lung Inducible Nitric Oxide Synthase Protein Does Not Correlate with Nitric Oxide Production in Vivo in a Pulmonary Immune Response Against Cryptococcus neoformans

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1772-1778

  Lovchik, Julie ^a,b   Lipscomb, Mary ^a   Lyons, C Rick ^a,b,c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Division of Pediatric Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CRYPTOCOCCOSIS; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; INNATE IMMUNITY; LUNG MYCOSIS; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; PATHOLOGY; SPECIES DIFFERENCE;

ANIMALS; CRYPTOCOCCOSIS; IMMUNITY, NATURAL; LUNG DISEASES, FUNGAL; MACROPHAGE ACTIVATION; MICE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SPECIES SPECIFICITY;

EID: 0031568391     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Huffnagle, G. B., and M. F. Lipscomb. 1992. Pulmonary cryptococcosis. Am. J. Pathol. 141:1517.
2. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
3. Lovchik, J. A., C. R. Lyons, and M. F. Lipscomb. 1995. A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:116.
4. Alspaugh, J. A.,and D. L. Granger. 1991. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291.
5. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487.
6. Locksley, R. M., and J. A. Louis. 1992. Immunology of leishmaniasis. Curr. Opin. Immunol. 4:413.
7. Locksley, R. M., and P. Scott. 1991. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today 12:A58.
8. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009.
9. Evans, T. G., L. Thai, D. L. Granger, and J. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in marine leishmaniasis. J. Immunol. 151: 907.
10. Forget, A., E. Skamene, P. Gros, A. Mialhe, and R. Turcotte. 1981. Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG. Infect. Immun. 32:42.
11. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate gene. Cell 73:469.
12. Vidal, S., P. Gros, and E. Skamene. 1995. Natural resistance to infection with intracellular parasites: molecular genetics identifies NRAMP1 as the BcglItylLsh locus. J. Leukocyte Biol. 58:382.
13. McKee, M., C. Scavone, and J. A. Nathanson. 1994. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. USA 91: 12056.
14. 15N]nitrate in biological fluids. Anal. Biochem. 1256:131.
15. Granger, D., J. Hibbs, Jr., and L. Broadnax. 1991. Urinary nitrate excretion in relation to murine macrophage activation. J. Immunol. 146:1294.
16. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
17. Nathan, C. F., and J. B. Hibbs. Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
18. Schini, V. B., R. Busse, and P. M. Vanhoutte. 1994. Inflammatory mediators induce the production of nitric oxide in vascular smooth muscle. Exp. Nephrol. 2:139.
19. Lorsbach, R. B., W. J. Murphy, C. J. Lowenstein, S. H. Snyder, and S. W. Russell. 1993. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem. 268:1908.
20. Oswald, I. P., S. Afroun, D. Bray, J. F. Petit, and G. Lemaire. 1992. Low response of BALB/c macrophages to priming and activating signals. J. Leukocyte Biol. 52:315.
21. Stuehr, D. J., and M. A. Marietta. 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82:7738.
22. Hibbs, I., Jr., C. Westenfelder, R. Taintor, Z. Vavrin, C. Kablitz, R. L. Baranowski, J. H. Ward, R. L. Menlove, M. P. McMurry, J. P. Kushner, and W. E. Samlowski. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy [published erratum appears in J. Clin. Invest. 90:295, 1992). J Clin Invest. 89:867.
23. Jacobs, P., D. Radzioch, and M. M. Stevenson. 1995. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J. Immunol. 155:5306.
24. Nathan, C. F., and Q. W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725.
25. Green, S. J., C. A. Nacy, R. D. Schreiber, D. L. Granger, R. M. Crawford, M. S. Meltzer, and A. R. Fortier. 1993. Neutralization of gamma interferon and tumor necrosis alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis in Mycobacterium bovis (BCG)-treated mice. J. Immunol 149:689.
26. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:605.
27. Kwon, N. S., C. F. Nathan, C. Gilker, O. W. Griffith, D. E. Matthews, and D. J. Stuehr. 1990. L-Citrulline production from L-arginine by macrophage nitric oxide synthase: the ureido oxygen derives from dioxygen. J. Biol. Chem. 265:13442.
28. Benninghoff, B., V. Lehmann, H. P. Eck, and W. Droge. 1991. Production of citrulline and ornithine by interferon-gamma treated macrophages. Int. Immunol. 3:413.
29. 2) in murine bone-marrow-derived macrophages. Biochem. Biophys. Res. Commun. 206:667.
30. Modolell, M., I. M. Corraliza, F. Link, G. Soler, and K. Eichmann. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25: 1101.
31. Sato, H., M. Fujiwara, and S. Bannai. 1992. Effect of lipopolysaccharide on transport and metabolism of arginine in mouse peritoneal macrophages. J. Leukocyte Biol. 52:161.
32. Gross, S. S., and R. Levi. 1992. Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:25722.
33. Sakai, N., S. Kaufman, and S. Milstein. 1993. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 254). Mol. Pharmacol. 43:6.
34. Muhl, H., and J. Pfeilschifter. 1994. Tetrahydrobiopterin is a limiting factor of nitric oxide generation in interleukin 1 beta-stimulated rat glomerular mesangial cells. Kidney Int. 46:1302.